Accord Company Profile

What is the competitive landscape for ACCORD, and what generic alternatives to ACCORD drugs are available?

ACCORD has one hundred and fifty-five approved drugs.

There are four US patents protecting ACCORD drugs. There are three tentative approvals on ACCORD drugs.

There are thirty-five patent family members on ACCORD drugs in eighteen countries and three hundred and eighty-six supplementary protection certificates in eighteen countries.

Summary for Accord

International Patents:	35
US Patents:	4
Tradenames:	132
Ingredients:	129
NDAs:	155
Patent Litigation for Accord:	See patent lawsuits for Accord
PTAB Cases with Accord as petitioner:	See PTAB cases with Accord as petitioner

Drugs and US Patents for Accord

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Accord Hlthcare	ANASTROZOLE	anastrozole	TABLET;ORAL	090568-001	Jun 28, 2010	AB	RX	No	No
Accord Hlthcare	GEMCITABINE HYDROCHLORIDE	gemcitabine hydrochloride	INJECTABLE;INJECTION	091594-003	Jul 25, 2011	AP	RX	No	No
Accord Hlthcare	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	209281-001	Feb 7, 2019	AB	RX	No	No
Accord Hlthcare	NALOXONE HYDROCHLORIDE	naloxone hydrochloride	INJECTABLE;INJECTION	216624-001	Oct 26, 2022	AP	RX	No	No
Accord Hlthcare	TRAZODONE HYDROCHLORIDE	trazodone hydrochloride	TABLET;ORAL	206923-003	Sep 8, 2017	AB	RX	No	No
Accord Hlthcare	DOCETAXEL	docetaxel	INJECTABLE;INJECTION	201195-002	Jun 8, 2011		DISCN	Yes	No

Paragraph IV (Patent) Challenges for ACCORD drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	for Injection	200 mcg/vial		2015-05-01
	for Injection	100 mcg/vial and 500 mcg/vial		2015-04-14

International Patents for Accord Drugs

Country	Patent Number	Estimated Expiration
Spain	2397712
Japan	5242415
Japan	7223021
China	101400363
Canada	2637569
Russian Federation	2008129201

Supplementary Protection Certificates for Accord Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1613288	CR 2011 00023	Denmark		PRODUCT NAME: FINGOLIMOD, HERUNDER FINGOLIMOD SOM HYDROCHLORID; REG. NO/DATE: EU/1/11/677/001-004 20110317
0430190	18/2005	Austria		PRODUCT NAME: PALONOSETRON, DESSEN SALZE UND STEREOISOMERE; REGISTRATION NO/DATE: EU/1/04/306/001 20050322
0720599	122004000026	Germany		PRODUCT NAME: EZETIMIB ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON IN KOMBINATION MIT SIMVASTATIN; NAT. REGISTRATION NO/DATE: 58866.00.00 58866.01.00 58866.02.00 58866.03.00 58870.00.00 58870.01.00 58870.02.00 58870.03.00 58874.00.00 58874.01.00 58874.02.00 58874.03.00 58878.00.00 58878.01.00 58878.02.00 58878.03.00 20040402 FIRST REGISTRATION: DE 58866.00.00 - 58866.03.00 58870.00.00 - 58870.03.00 58874.00.00 - 58874.03.00 58878.00.00 - 58878.03.00 20040402
0503785	CA 2009 00015	Denmark		PRODUCT NAME: EN KOMBINATION AF OLMESARTANMEDOXOMIL, EVT. I FORM AF ET FARMACEUTISK ACCEPTABELT SALT OG AMLODIPIN-BESILAT; NAT. REG. NO/DATE: MT 42061, 42062, 42063 20081120; FIRST REG. NO/DATE: NL RVG 100984 20080819
1613288	122011100047	Germany		PRODUCT NAME: FINGOLIMOD ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ HIERVON; NAT. REGISTRATION NO/DATE: FIRST REGISTRATION: EU EU/1/11/677/001-004 20110317EU/1/11/677/001 EU/1/11/677/002 EU/1/11/677/003 EU/1/11/677/004 20110317
0275821	SPC/GB01/039	United Kingdom		PRODUCT NAME: ZOLEDRONIC ACID OPTIONALLY IN THE FORM OF A SALT THEREOF; NATIONAL REGISTRATION NO/DATE: EU/1/01/176/001-003 20010320; FIRST REGISTRATION: CH 55463 20001128

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Accord
• Accord Hlthcare
• Accord Hlthcare Inc